John C. van Swieten

62.3k citations

268 papers · 23.7k indexed · 6 hit papers · h-index 64

Co-authors: J. van Gijn Peter J. Koudstaal Marieke C. Visser H J Schouten Peter Heutink Monique M.B. Breteler Albert Hofman Lize C. Jiskoot
Topics: Alzheimer's disease research and treatments (115 papers)Dementia and Cognitive Impairment Research (83 papers)Amyotrophic Lateral Sclerosis Research (75 papers)
Cited by: Neurology Psychiatry and Mental health
Journals: Science The Lancet Nature Communications
Partner nations: Netherlands United States United Kingdom

In The Last Decade

John C. van Swieten

260 papers receiving 23.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interobserver agreement for the assessment of handicap in stroke patients.

1988 4.9k citations John C. van Swieten et al. profile →
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

2003 2.2k citations Guido J. Breedveld, John C. van Swieten et al. profile →
Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia

2017 1.4k citations Esther van den Berg, Lize C. Jiskoot et al. profile →
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study

1994 814 citations Monique M.B. Breteler, John C. van Swieten et al. Neurology profile →
Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study

2005 609 citations John C. van Swieten, Monique M.B. Breteler et al. profile →
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.

2004 603 citations John C. van Swieten, Monique M.B. Breteler et al. profile →

Peers

Countries citing papers authored by John C. van Swieten

Since Specialization

Citations

This map shows the geographic impact of John C. van Swieten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. van Swieten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. van Swieten more than expected).

Fields of papers citing papers by John C. van Swieten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. van Swieten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. van Swieten. The network helps show where John C. van Swieten may publish in the future.

Co-authorship network of co-authors of John C. van Swieten

This figure shows the co-authorship network connecting the top 25 collaborators of John C. van Swieten. A scholar is included among the top collaborators of John C. van Swieten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. van Swieten. John C. van Swieten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Allosteric modulation of protein kinase A in individuals affected by NLPD ‐ PKA , a neurodegenerative disease in which the PRKAR1B L50R variant is expressed 2025 ·FEBS Journal ·(unknown),(unknown),(unknown),(unknown),Varda Lev‐Ram,(unknown),(unknown),Daniela Bertinetti,Andrew J. Hoy,Merel O. Mol,John C. van Swieten,Rodrigo A. Maillard,Friedrich W. Herberg,Ronit Ilouz	0
2	Investigating the role of neuroinflammation and brain clearance in frontotemporal lobar degeneration using 7T MRI and fluid biomarkers: protocol for a cross-sectional study in a tertiary care setting 2025 ·BMJ Open ·(unknown),Louise van der Weerd,John C. van Swieten,Itamar Ronen,Harro Seelaar,Lydiane Hirschler,Chloé Najac,Elise G.P. Dopper	2
3	Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia 2025 ·Molecular Neurodegeneration ·(unknown),Lisa Vermunt,Carel F.W. Peeters,Emma L. van der Ende,(unknown),Lieke Meeter,(unknown),Harro Seelaar,John C. van Swieten,William T. Hu,Alberto Lleó,Daniel Alcolea,Sebastiaan Engelborghs,Anne Sieben,Alice Chen‐Plotkin,David J. Irwin,Wiesje M. van der Flier,Yolande A.L. Pijnenburg,Charlotte E. Teunissen,Marta del Campo	1
4	Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history 2024 ·Journal of Neurology ·(unknown),Elise G.P. Dopper,(unknown),(unknown),Marina Arcaro,Daniela Galimberti,Guido J. Breedveld,Martina Wilke,Rick van Minkelen,Lize C. Jiskoot,John C. van Swieten,Laura Donker Kaat,Harro Seelaar	1
5	The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration 2023 ·Science Translational Medicine ·Jiechao Zhou,Sarah D. Wade,David Graykowski,Mei-Fang Xiao,(unknown),Lucia Giannini,Jesse E. Hanson,John C. van Swieten,Morgan Sheng,Paul Worley,Borislav Dejanovic	69
6	Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia 2023 ·Neurology Neuroimmunology & Neuroinflammation ·Anna E.M. Bastiaansen,(unknown),(unknown),Wiesje M. van der Flier,Charlotte E. Teunissen,Esther de Graaff,Mariska M.P. Nagtzaam,Manuela Paunovic,(unknown),Marco W.J. Schreurs,Frank Leypoldt,Peter A.E. Sillevis Smitt,Juna M. de Vries,Harro Seelaar,John C. van Swieten,Frank Jan de Jong,Yolande A.L. Pijnenburg,Maarten J. Titulaer	17
7	CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease 2023 ·Brain ·Emma L. van der Ende,Sjors G. J. G. In ‘t Veld,(unknown),Sven J. van der Lee,Janna I.R. Dijkstra,(unknown),(unknown),John C. van Swieten,David J. Irwin,Alice Chen‐Plotkin,William T. Hu,Afina W. Lemstra,Yolande A.L. Pijnenburg,Wiesje M. van der Flier,Marta del Campo,Charlotte E. Teunissen,Lisa Vermunt	27
8	Frontotemporal lobar degeneration 2023 ·Nature Reviews Disease Primers ·Murray Grossman,William W. Seeley,Adam L. Boxer,Argye E. Hillis,David S. Knopman,(unknown),Bruce L. Miller,Olivier Piguet,Rosa Rademakers,Jennifer L. Whitwell,Henrik Zetterberg,John C. van Swieten	70
9	Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex 2022 ·Nature Neuroscience ·Emma Gerrits,Lucia Giannini,Nieske Brouwer,Shamiram Melhem,Danielle Seilhean,Isabelle Le Ber,(unknown),Alwin Kamermans,Gijs Kooij,Helga E. de Vries,Erik Boddeke,Harro Seelaar,John C. van Swieten,Bart J. L. Eggen	43
10	The severity of behavioural symptoms in FTD is linked to the loss of GABRQ‐expressing VENs and pyramidal neurons 2022 ·Neuropathology and Applied Neurobiology ·Priya Gami‐Patel,Marta Scarioni,Femke H. Bouwman,Baayla D.C. Boon,John C. van Swieten,(unknown),Annemieke J.M. Rozemüller,August B. Smit,Yolande A.L. Pijnenburg,Jeroen J.M. Hoozemans,Anke A. Dijkstra	9
11	Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid 2022 ·Neurobiology of Disease ·(unknown),Anke A. Dijkstra,Alberto Rábano,Jeroen J.M. Hoozemans,(unknown),Harro Seelaar,John C. van Swieten,Yolande A.L. Pijnenburg,Charlotte E. Teunissen,Marta del Campo	3
12	SomaticTARDBPvariants as a cause of semantic dementia 2020 ·Brain ·Jeroen van Rooij,Merel O. Mol,Shamiram Melhem,(unknown),Pascal Arp,(unknown),Laura Donker Kaat,Harro Seelaar,(unknown),Suzanne S. M. Miedema,(unknown),Bart J. L. Eggen,André G. Uitterlinden,Joyce B. J. van Meurs,Ronald E. van Kesteren,August B. Smit,Emanuele Buratti,John C. van Swieten	17
13	Differences in Discriminability and Response Bias on Rey Auditory Verbal Learning Test Delayed Recognition in Behavioral Variant Frontotemporal Dementia and Alzheimer’s Disease 2020 ·Journal of the International Neuropsychological Society ·Esther van den Berg,Jackie M. Poos,Lize C. Jiskoot,(unknown),Sanne Franzen,Rebecca M. E. Steketee,Rozanna Meijboom,Frank Jan de Jong,Harro Seelaar,John C. van Swieten,Janne M. Papma	8
14	Review: Fluid biomarkers for frontotemporal dementias 2018 ·Neuropathology and Applied Neurobiology ·Henrik Zetterberg,John C. van Swieten,Adam L. Boxer,Jonathan D. Rohrer	33
15	Hippocampal transcriptome profiling combined with protein-protein interaction analysis elucidates Alzheimer's disease pathways and genes 2018 ·Neurobiology of Aging ·Jeroen van Rooij,Lieke Meeter,(unknown),Diana A.T. Nijholt,Tsz Hang Wong,Annemieke J.M. Rozemüller,André G. Uitterlinden,Joyce B. J. van Meurs,John C. van Swieten	32
16	EIF2AK3 variants in Dutch patients with Alzheimer's disease 2018 ·Neurobiology of Aging ·Tsz Hang Wong,Sven J. van der Lee,Jeroen van Rooij,Lieke Meeter,Petra Frick,Shamiram Melhem,Harro Seelaar,M. Arfan Ikram,Annemieke J.M. Rozemüller,Henne Holstege,Marc Hulsman,André G. Uitterlinden,Manuela Neumann,Jeroen J.M. Hoozemans,Cornelia M. van Duijn,(unknown),John C. van Swieten	9
17	¹⁸ F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers 2016 ·Brain ·Ruben Smith,Andreas Puschmann,Michael Schöll,Tomas Ohlsson,John C. van Swieten,Michael Honer,Elisabet Englund,Oskar Hansson	130
18	A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds 2016 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Petra E. Cohn‐Hokke,Henne Holstege,Marjan M. Weiss,Wiesje M. van der Flier,Frederik Barkhof,Erik A. Sistermans,Yolande A.L. Pijnenburg,John C. van Swieten,Hanne Meijers‐Heijboer,Philip Scheltens	4
19	Familial aggregation of parkinsonism in progressive supranuclear palsy 2009 ·Neurology ·Laura Donker Kaat,Agnita J.W. Boon,Asma Azmani,Wouter Kamphorst,Monique M.B. Breteler,Burcu Anar,Peter Heutink,John C. van Swieten	42
20	New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 2002 ·Current Opinion in Neurology ·Sonia M. Rosso,John C. van Swieten	34

About John C. van Swieten

John C. van Swieten is a scholar working on Neurology, Psychiatry and Mental health and Neurology, having authored 268 papers that have together received 23.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (115 papers), Dementia and Cognitive Impairment Research (83 papers) and Amyotrophic Lateral Sclerosis Research (75 papers). The work is most often cited by research in Neurology (10.0k citations), Neurology (4.2k citations) and Psychiatry and Mental health (4.9k citations). John C. van Swieten has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include J. van Gijn, Peter J. Koudstaal, Marieke C. Visser, H J Schouten, Peter Heutink, Monique M.B. Breteler, Albert Hofman, Lize C. Jiskoot, Cornelia M. van Duijn and Annemieke Ruitenberg. Their work appears in journals such as Science, The Lancet and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact